Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 7, 2012, Pages 846-853

  Justino, Maria Cleonice A ^a   Araújo, Eliete C ^b   van Doorn, Leen Jan ^c   Oliveira, Consuelo S ^a   Gabbay, Yvone B ^a   Mascarenhas, Joana D'Arc P ^a   Miranda, Yllen S ^a   Guerra, Sylvia de Fátima S ^a   da Silva, Veronilce B ^a   Linhares, Alexandre C ^a  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c DDL Diagnostic Laboratory   (Netherlands)

Author keywords

G9P 8 strains; Gastroenteritis; Rotavirus; Vaccine efficacy

Indexed keywords

LIVE VACCINE; RIX4414 VACCINE; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROENTERITIS; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INFANT; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS INFECTION; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADMINISTRATION, ORAL; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; INFANT; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX; VACCINES, ATTENUATED;

HUMAN ROTAVIRUS A; ROTAVIRUS;

EID: 84869194013     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000700002     Document Type: Article

References (36)

1. Araujo EC, Clemens S-AC, Oliveira CS, Justino MCA, Rubio P, Gabbay YB, da Silva VB, Mascarenhas JDP, Noronha VL, Clemens R, Gusmão RHP, Sanchez N, Monteiro TAF, Linhares AC 2007. Safety, immunogenicity and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Ped 83: 217-224.
2. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schödel F, Ciarlet M, Neuzil KM 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376: 606-614.
3. Bernstein DI 2009. Rotavirus overview. Pediatr Infect Dis J 28 (Suppl. 3): S50-S53.
4. Correia JB, Patel MM, Nakagomi O, Montenegro FMU, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T 2010. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 201: 363-369.
5. Cubitt WD, Steele AD, Iturriza-Gomara M 2000. Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6]. J Med Virol 61: 150-154.
6. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, de Oliveira LH, Kerin T, Bowen M, Gentsch J, Espósito DH, Parashar U, Tate J, Patel M 2010. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 340: c2825.
7. de Vos B, Han HH, Bouckenooghe A, Debrus S, Gillard P, Ward R, Cheuvart B 2009. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and p genotypes. Pediatr Infect Dis J 28: 261-266.
8. Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CFB, Tate JE, Matus CR, Andrus JK, Patel MM 2012. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clin Infect Dis 54: 1397-1405.
9. do Carmo GMI, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, Patel M 2011. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. Plos Med 8: e1001024.
10. Gentsch J, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD, Fischer TK, Parashar UD, Bresee JS, Jiang B, Glass RI 2005. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192 (Suppl.): S146-S159.
11. Gurgel RG, Bohland AK, Vieira SC, Oliveira DM, Fontes PB, Barros VF, Ramos MF, Dove W, Nakagomi T, Nakagomi O, Correia JB, Cunliffe N, Cuevas LE 2009. Incidence of rotavirus and all-cause diarrhea in Northeast Brazil following the introduction of a national vaccination program. Gastroenterology 137: 1970-1975.
12. Iturriza-Gomara M, Green J, Brown DWG, Ramsay M, Desselberger U, Gray J 2000. Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998. J Clin Microbiol 38: 4394-4401.
13. Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JDP, Abreu E, Guerra SFS, Oliveira ASL, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE 2011. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J 30: 396-401.
14. Lanzieri TM, Costa I, Shafi FA, Cunha MH, Ortega-Barria E, Linhares AC, Colindres RE 2010. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J 29: 673-675.
15. Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE 2011. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis 15: e206-210.
16. Linhares AC, Gabbay YB, Mascarenhas JDP, Freitas RB de, Oliveira CS, Bellesi N, Monteiro TAF, Lins-Lainson Z, Ramos FLP 1996. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bull World Health Organ 74: 491-500.
17. Linhares AC, Stupka, JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, Mazzoni A, Buendía Rodriguez JA, Rearte A, Lanzieri T, Ortega-Barria E, Colindres RE 2011. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Rev Med Virol doi: 10.1002/rmv.682.
18. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, de Vos B, O'Ryan M, Gillard P, Bouckenooghe A 2008. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371: 1181-1189.
19. Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T 2006. Rotavirus serotype G9 is associated with more-severe disease in Latin America. CID 43: 312-314.
20. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362: 289-298.
21. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M 2009. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 4: 1303-1316.
22. Matthijnssens J, Ciarlet M, McDonald SM, Attoi H, Bányai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gómara M, Johne R, Kirkwood CD, Martella V, Mertens PPC, Nakagomi O, Parreño V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M 2011. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 156: 1397-1413.
23. Molto Y, Cortes JE, de Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM 2011. Reduction of diarrhoea-associated hospitalizations among children aged < 5 years in Panama following the introduction of rotavirus vaccine. Pediatric Infect Dis J 30 (Suppl. 1): S16-S20.
24. TM: an oral human rotavirus vaccine. Expert Rev Vaccines 8: 1627-1641.
25. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI 2009. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 200 (Suppl. 1): S9-S15.
26. Richardson V, Hernández-Pichardo J, Quintanar-Soares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M 2010. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 362: 299-305.
27. Ruiz-Palacios G, Pérez-Schael I, Velázquez RF, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, de Vos B, O'Ryan M, Gillard P, Bouckenooghe A, Human Rotavirus Vaccine Study Group 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11-22.
28. Ruuska T, Vesikari T 1990. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 22: 259-267.
29. Salinas B, Pérez-Schael I, Linhares AC, Ruiz-Palacios GM, Guerrero ML, Yarzábal JP, Cervantes Y, Costa Clemens SA, Damaso S, Hardt K 2005. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414. Pediatr Infect Dis J 24: 807-816.
30. Santos N, Hoshino Y 2005. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15: 29-26.
31. Siqueira AA, Santelli ACFS, Alencar LR, Dantas MP, Dimech CPN, Carmo GMI, Santos DA, Alves RMS, Lucena MBF, Morais M, Assis RMS, Fialho A, Mascarenhas JDP, Costa M, Linhares AC, Leite JPG, Araujo WN, Hatch DL 2010. Outbreak of acute gastroenteritis in young children with death due to rotavirus genotype G9 in Rio Branco, Brazilian Amazon Region, 2005. Int J Infect Dis 14: e898-903.
32. Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, Carapetis JR 2009. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. CID 49: 428-431.
33. Tate JE, Burton HA, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network 2012. 2008 estimate of worldwide rotavirus associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12: 136-141.
34. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A 2007. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind, placebo-controlled study. Lancet 370: 1757-1763.
35. WHO-World Health Organization 2009. Meeting of the Immunization Strategic Advisory Group of Experts, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 84: 518.
36. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schödel F, Steele AD, Neuzil KM, Ciarlet M 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376: 615-623.